Johnson Financial Group Inc (Wisconsin)’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
RJFSA
Johnson Financial Group Inc (Wisconsin)'s ARKG Position: Q1 2023 in Review
Johnson Financial Group Inc (Wisconsin) sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2023, closing a stake of 907 shares — an estimated $25.6K sold.
Johnson Financial Group Inc (Wisconsin) first reported a position in ARKG in Q1 2021 and held it in 8 quarters. The position peaked at $137K in Q2 2021. 295 funds tracked by Wall St. Rank hold ARKG as of Q1 2023.
- Johnson Financial Group Inc (Wisconsin) reported no remaining ARK Genomic Revolution ETF position as of Q1 2023 after selling out during the quarter.
- Johnson Financial Group Inc (Wisconsin) sold 907 ARK Genomic Revolution ETF shares in Q1 2023, an estimated $25.6K.
- Johnson Financial Group Inc (Wisconsin) first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 8 quarters.
- Johnson Financial Group Inc (Wisconsin)'s ARK Genomic Revolution ETF position peaked at $137K in Q2 2021.
- 295 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2023.
Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q1 2023, filed 12 May 2023.